Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for Cancer Related Anorexia-cachexia Syndrome
NCT06517199Phase 3Recruiting
- Sponsor
- Mahidol University
- Start
- Jan 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in cancer anorexia-cachexia syndrome (CACS), sponsored by Mahidol University. Started Jan 2024; status: recruiting.
02
Drugs
olanzapine
03
Conditions
cancer anorexia-cachexia syndrome (CACS)
Beyond the preview
Go deeper on NCT06517199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06517199.